Kimberly Wehger
Chief Tech/Sci/R&D Officer bei ARVINAS, INC.
Profil
Kimberly Wehger ist Vizepräsidentin für Informationstechnologie bei Arvinas, Inc. In der Vergangenheit war Kimberly Wehger Chief Information Officer & Vice President bei New Haven Pharmaceuticals, Inc. und Director-Business Engagement bei Alexion Pharmaceuticals, Inc. sowie Practice Manager-R&D Managed Services bei Veeva Systems, Inc. Sie erwarb einen Bachelor-Abschluss an der State University of New York in Binghamton und einen Master-Abschluss an der Southern Connecticut State University.
Aktive Positionen von Kimberly Wehger
| Unternehmen | Position | Beginn |
|---|---|---|
| ARVINAS, INC. | Chief Tech/Sci/R&D Officer | - |
Ehemalige bekannte Positionen von Kimberly Wehger
| Unternehmen | Position | Ende |
|---|---|---|
New Haven Pharmaceuticals, Inc.
 New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Chief Tech/Sci/R&D Officer | 01.01.2016 |
| ALEXION PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| VEEVA SYSTEMS INC. | Corporate Officer/Principal | - |
Ausbildung von Kimberly Wehger
| Southern Connecticut State University | Graduate Degree |
| State University of New York at Binghamton | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| VEEVA SYSTEMS INC. | Technology Services |
| ARVINAS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
New Haven Pharmaceuticals, Inc.
New Haven Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology New Haven Pharmaceuticals, Inc. develops new prescription drug products. It developes proprietary prescription pharmaceuticals that utilize currently marketed drugs or generally recognized as safe (GRAS) active pharmaceutical ingredients (APIs) for use in therapeutic applications. The company was founded by Harry H. Penner Jr. in 2008 and is headquartered in Branford, CT. | Health Technology |
